385 related articles for article (PubMed ID: 1300765)
21. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
[TBL] [Abstract][Full Text] [Related]
22. Assessing sequential oncogene amplification in human breast cancer.
Janocko LE; Lucke JF; Groft DW; Brown KA; Smith CA; Pollice AA; Singh SG; Yakulis R; Hartsock RJ; Shackney SE
Cytometry; 1995 Sep; 21(1):18-22. PubMed ID: 8529465
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
Prati R; Apple SK; He J; Gornbein JA; Chang HR
Breast J; 2005; 11(6):433-9. PubMed ID: 16297088
[TBL] [Abstract][Full Text] [Related]
24. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
Gong Y; Booser DJ; Sneige N
Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
[TBL] [Abstract][Full Text] [Related]
25. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
Iglehart JD; Kraus MH; Langton BC; Huper G; Kerns BJ; Marks JR
Cancer Res; 1990 Oct; 50(20):6701-7. PubMed ID: 2208136
[TBL] [Abstract][Full Text] [Related]
26. HER-2/neu amplification predicts poor survival in node-positive breast cancer.
Borg A; Tandon AK; Sigurdsson H; Clark GM; Fernö M; Fuqua SA; Killander D; McGuire WL
Cancer Res; 1990 Jul; 50(14):4332-7. PubMed ID: 1973070
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between int-2 oncogene amplification and increased tumor size in breast cancer].
Chernitsa OI; Laur OI; Imianitov EN; Cheburkin IV; Belogubova EV; Iliushik ES; Zaĭtseva OA; Togo AV; Ivanova OA; Kniazev PG; Semiglazov VF; Khanson KP
Vopr Onkol; 1996; 42(4):27-9. PubMed ID: 8928453
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer.
Zadrozny M; Smolarz B; Romanowicz-Makowska H; Kozłowska E; Kulig A
Pol J Pathol; 2002; 53(4):189-93. PubMed ID: 12597335
[TBL] [Abstract][Full Text] [Related]
29. [Cancer metastasis and recurrence from the standpoint of amplification and expression of oncogenes in human malignant tumors].
Kikuchi K; Ueda M; Kitagawa Y; Ando N; Abe O
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1090-3. PubMed ID: 1944161
[TBL] [Abstract][Full Text] [Related]
30. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
[TBL] [Abstract][Full Text] [Related]
31. [Preliminary studies on c-erbB-2 protooncogene in breast cancer].
He LW
Zhonghua Zhong Liu Za Zhi; 1992 May; 14(3):171-4. PubMed ID: 1356719
[TBL] [Abstract][Full Text] [Related]
32. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
33. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
Persons DL; Borelli KA; Hsu PH
Mod Pathol; 1997 Jul; 10(7):720-7. PubMed ID: 9237184
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.
van de Vijver MJ; Mooi WJ; Wisman P; Peterse JL; Nusse R
Oncogene; 1988 Feb; 2(2):175-8. PubMed ID: 3285295
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer.
Homaei-Shandiz F; Ghavam-Nassiri MR; Sharifi N; Homaei-Shandiz AH; Taghizadeh-Kermani A; Torshizi SA; Ghafarzadegan K
Saudi Med J; 2006 Dec; 27(12):1810-4. PubMed ID: 17143354
[TBL] [Abstract][Full Text] [Related]
37. Amplification of the c-myc oncogene in human stomach cancers.
Nakasato F; Sakamoto H; Mori M; Hayashi K; Shimosato Y; Nishi M; Takao S; Nakatani K; Terada M; Sugimura T
Gan; 1984 Sep; 75(9):737-42. PubMed ID: 6500230
[TBL] [Abstract][Full Text] [Related]
38. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
Machotka SV; Garrett CT; Schwartz AM; Callahan R
Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
[TBL] [Abstract][Full Text] [Related]
39. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
Friedrichs K; Lohmann D; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
[TBL] [Abstract][Full Text] [Related]
40. [Molecular biological and biochemical features of breast cancer].
Khanson KP; Bershteĭn LM; Imianitov EN; Tsyrlina EV; Semiglasov VF
Vestn Ross Akad Med Nauk; 1998; (1):15-9. PubMed ID: 9511435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
